Oral Administration of Rhamnan Sulfate from


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
20 Nov 2023
Historique:
received: 12 10 2023
revised: 10 11 2023
accepted: 16 11 2023
medline: 27 11 2023
pubmed: 24 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

Oral administration of rhamnan sulfate (RS), derived from the seaweed

Identifiants

pubmed: 37998401
pii: cells12222666
doi: 10.3390/cells12222666
pmc: PMC10670814
pii:
doi:

Substances chimiques

rhamnan 111018-90-7
Sulfates 0
Apolipoproteins E 0
RNA, Messenger 0
Robo4 protein, mouse 0
Receptors, Cell Surface 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 18H05299
Organisme : Japan Society for the Promotion of Science
ID : 19K08850
Organisme : Japan Society for the Promotion of Science
ID : 22K08489

Références

PLoS One. 2013 May 23;8(5):e63374
pubmed: 23717417
Biosci Biotechnol Biochem. 1998 Sep;62(9):1647-52
pubmed: 9805364
Cell Rep. 2015 Sep 22;12(11):1802-15
pubmed: 26344769
Biomaterials. 2022 Dec;291:121865
pubmed: 36332287
Cardiovasc Diabetol. 2018 Jul 26;17(1):106
pubmed: 30049285
Int J Mol Sci. 2019 Jun 07;20(11):
pubmed: 31181661
Acta Physiol (Oxf). 2009 Jun;196(2):193-222
pubmed: 19220204
Mar Drugs. 2021 Nov 30;19(12):
pubmed: 34940684
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1662-7
pubmed: 11597942
Mol Biotechnol. 2014 Apr;56(4):329-39
pubmed: 24146429
Mar Drugs. 2020 May 13;18(5):
pubmed: 32414158
J Clin Invest. 1995 Aug;96(2):1169-75
pubmed: 7635955
Biochem Pharmacol. 2009 Sep 15;78(6):539-52
pubmed: 19413999
Int J Mol Med. 2011 Aug;28(2):247-53
pubmed: 21567073
Biochim Biophys Acta. 2015 Oct;1849(10):1248-59
pubmed: 26260845
Int J Mol Sci. 2022 Dec 21;24(1):
pubmed: 36613514
Shock. 2014 Apr;41(4):275-81
pubmed: 24430552
Mar Drugs. 2020 Apr 24;18(4):
pubmed: 32344720
Blood Coagul Fibrinolysis. 1995 Jun;6 Suppl 1:S26-31
pubmed: 7647217
Immunol Today. 1997 May;18(5):231-40
pubmed: 9153955
Thromb Haemost. 1994 Jul;72(1):132-9
pubmed: 7974361
J Exp Med. 1991 Jun 1;173(6):1553-7
pubmed: 1709678
Cell. 1994 Jan 28;76(2):301-14
pubmed: 7507411
J Mol Endocrinol. 2011 Aug 03;47(1):81-97
pubmed: 21610007
Nat Commun. 2015 Jul 17;6:7770
pubmed: 26183159
J Nat Med. 2019 Jun;73(3):614-619
pubmed: 30796650
Am J Pathol. 1977 Mar;86(3):675-84
pubmed: 842616
Mar Drugs. 2018 Jul 20;16(7):
pubmed: 30037033
J Biomol Struct Dyn. 2023 Oct 9;:1-16
pubmed: 37811743
Int J Biol Macromol. 2016 Oct;91:846-55
pubmed: 27288698
Exp Cell Res. 2019 Sep 15;382(2):111472
pubmed: 31229505
Exp Dermatol. 2014 Sep;23(9):659-63
pubmed: 25041031
Nature. 2011 May 19;473(7347):317-25
pubmed: 21593864
Planta Med. 1999 Jun;65(5):439-41
pubmed: 10418331
Sci Rep. 2021 Jul 5;11(1):13384
pubmed: 34226572
J Clin Invest. 2001 Feb;107(3):255-64
pubmed: 11160146
Blood. 1988 Jan;71(1):1-8
pubmed: 3275472
Arterioscler Thromb Vasc Biol. 1998 May;18(5):842-51
pubmed: 9598845
J Cell Sci. 2019 Jan 2;132(1):
pubmed: 30510113
J Clin Invest. 2001 May;107(10):1255-62
pubmed: 11375415
J Biomed Mater Res A. 2020 Jan;108(1):94-102
pubmed: 31498963
Mar Drugs. 2022 Feb 03;20(2):
pubmed: 35200650
Bioresour Technol. 2012 Jun;114:414-8
pubmed: 22472640
Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1006-14
pubmed: 15087308

Auteurs

Masahiro Terasawa (M)

Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.
Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.

Liqing Zang (L)

Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan.

Keiichi Hiramoto (K)

Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.

Yasuhito Shimada (Y)

Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.

Mari Mitsunaka (M)

Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.

Ryota Uchida (R)

Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.
Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.

Kaoru Nishiura (K)

Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.

Koichi Matsuda (K)

Konan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.

Norihiro Nishimura (N)

Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan.

Koji Suzuki (K)

Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH